Mumbai, June 18, 2010: Sun Pharma announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) to market a generic version of Xanax ®, alprazolam tablets.

Gurgaon, India and Tokyo, Japan - Daiichi Sankyo Company Limited ("Daiichi Sankyo") and Ranbaxy Laboratories Limited ("Ranbaxy") announced today that Ranbaxy has launched a generic version of Prasugrel in India. The product, called Prasita, is an antiplatelet agent for the prevention of atherothrombotic events in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Prasita is solely marketed by Ranbaxy in India.

Setting its sights onto the Rs 720 crore market for smoking cessation products or nicotine replacement therapy (NRT) products, the Rs 700 cr Elder Pharmaceuticals Ltd (NSE: ELDERPHARM) has entered into an exclusive manufacturing tie-up with M/s Gelnova Laboratories of Navi Mumbai to introduce for the first time in world NRT products in pastille form.

Ten months after the Mumbai, India based drug maker Elder Pharmaceuticals Limited (BSE: ELDERPHARM) expanded & modernized its R&D centre, its scientists have come up with a Novel Drug Delivery System (NDDS) for a Nutracuetical formulation called Coenzyme Q(10) [CO Q10] enabling Elder to become the first company in the world to launch this nutraceutical in a novel form.

Bangalore - In line with the rising need for organ donation in the state, Columbia Asia Hospitals Pvt. Ltd. in close collaboration with Zonal Coordination Committee of Karnataka for Transplantation (ZCCK) today organized a panel discussion. The forum was addressed by 'Naadoja' Dr Justice S R Nayak, Chairperson of Karnataka State Human Rights Commission and Dr D. Ramesh, Secretary, ZCCK.

Brussels - The International Diabetes Federation (IDF) today kicked off its World Diabetes Day campaign under the slogan "Let's take control of diabetes. Now."

Mumbai - LANXESS India Private Limited, specialty chemicals company has issued new Personal Medical Cards to each of its employees at Nagda carrying the medical status of each employee. This is consequent to comprehensive health check-up carried out for all employees by a reputed industrial doctor from Mumbai.

Bangalore – Stempeutics Research Pvt. Ltd., a group company of Manipal Education & Medical Group announced today that it has completed the initial Phase I/II clinical trial of its product “Stempeucel-CLI”. This multi centric, placebo controlled, double blind trial was approved by DCGI last year (2009). Stempeucel-CLI is a stem cell based product developed using mesenchymal stem cells derived from donated bone marrow, for Critical Limb Ischemia (CLI) patients.

Mumbai - When it comes to treating minor ailments, Indians rely more on the advice of doctors rather than their neighbourhood pharmacists, according to a new global study by The Nielsen Company.